Player FM 앱으로 오프라인으로 전환하세요!
Improving Cost and Care Through Data Transparency with Arrive Health CEO Kyle Kiser
Manage episode 363544392 series 2934463
In this episode, you will discover:
- Why price transparency is important
- How to understand the impact between a $0 option and a $250 option in the moment of decision
- How data transparency impacts patient access and health equity
Key Takeaways:
- Moving to a more consumer-directed and consumer-focused model means focusing on creating more transparency on the area of pricing. By bringing this information upstream, we will be able to build trust between the patient and the provider.
- The difference between a $250 drug and a $0 drug can be meaningful to a lot of people. Providing this option isn’t impossible, it’s only a matter of getting the right answer to the right decision-maker when those things are happening.
- Consumer-driven healthcare is the most important health equity issue to solve. Half of America can’t incur $1,000 of unexpected expenses without financial ruin. Providing information to the right people can go a long way in contributing to the solution.
“Things that we can automate, we should automate.” - Kyle Kiser
Resources:
Website: https://arrivehealth.com/
LinkedIn: https://www.linkedin.com/in/kyle-kiser-68ba218/
Learn more from Carrie and Rebecca:
Healthcare Insights (a monthly deep dive into specific topics for innovators): https://nixongwiltlaw.com/healthcare-insights
Telehealth/Virtual Care Mgmt Update (a biweekly LinkedIn newsletter tracking legal and policy changes across the nation): https://www.linkedin.com/newsletters/telehealth-virtual-care-update-6901900767960068096/
Website: https://nixongwiltlaw.com/
Carrie on LinkedIn: https://www.linkedin.com/in/carrienixon/
Rebecca on LinkedIn: https://www.linkedin.com/in/rebeccagwilt/
NGL on LinkedIn: https://www.linkedin.com/company/nixon-gwilt-law/
65 에피소드
Manage episode 363544392 series 2934463
In this episode, you will discover:
- Why price transparency is important
- How to understand the impact between a $0 option and a $250 option in the moment of decision
- How data transparency impacts patient access and health equity
Key Takeaways:
- Moving to a more consumer-directed and consumer-focused model means focusing on creating more transparency on the area of pricing. By bringing this information upstream, we will be able to build trust between the patient and the provider.
- The difference between a $250 drug and a $0 drug can be meaningful to a lot of people. Providing this option isn’t impossible, it’s only a matter of getting the right answer to the right decision-maker when those things are happening.
- Consumer-driven healthcare is the most important health equity issue to solve. Half of America can’t incur $1,000 of unexpected expenses without financial ruin. Providing information to the right people can go a long way in contributing to the solution.
“Things that we can automate, we should automate.” - Kyle Kiser
Resources:
Website: https://arrivehealth.com/
LinkedIn: https://www.linkedin.com/in/kyle-kiser-68ba218/
Learn more from Carrie and Rebecca:
Healthcare Insights (a monthly deep dive into specific topics for innovators): https://nixongwiltlaw.com/healthcare-insights
Telehealth/Virtual Care Mgmt Update (a biweekly LinkedIn newsletter tracking legal and policy changes across the nation): https://www.linkedin.com/newsletters/telehealth-virtual-care-update-6901900767960068096/
Website: https://nixongwiltlaw.com/
Carrie on LinkedIn: https://www.linkedin.com/in/carrienixon/
Rebecca on LinkedIn: https://www.linkedin.com/in/rebeccagwilt/
NGL on LinkedIn: https://www.linkedin.com/company/nixon-gwilt-law/
65 에피소드
כל הפרקים
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.